To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.
KAYTO 2021 logo
The Know All Your Treatment Options virtual event is presented annually by the End Brain Cancer Initiative. We bring together medical professionals, caregivers and patients with the following objectives :
  • Learn
  • Be inspired
  • Share
The event was recorded and the full event video is available using the button below. Descriptions of the individual presentations and direct links to those sections of the video are available as you scroll down this page.
View The Event Video
Bruce Rinker photo

National Hope Award

The End Brain Cancer Initiative presents the annual National Hope Award to honor a patient who embodies hope in their brain tumor journey.
View the 2021 hope award presentationBruce Rinker in his own words
Dr. Smith photo
Dr. Kris Smith
Director: Stereotactic/Functional/Epilepsy Fellowship Program
Co-Director: Neurosurgical Oncology and Radiosurgery
Director: NPH and Hypothalamic Hamartoma Programs
Barrow Neurological Institute

Dr. Kris Smith

Advances in Treating Patients
GammaTile Combined with Ketogenic Metabolic Therapy: A Better Chance for Long-Term Survival and QOL Preservation?

Dr. Kris Smith describes his father’s GBM journey that led to Dr. Smith’s insight into the disease, its cause and treatment. He advocates the use of metabolic treatment based on a ketogenic diet combined with radiation and chemotherapy treatments. Dr. Smith describes the GammaTile device, which is an implanted radiation source.
View this presentation
Dr. Venur photo
Dr. Vyshak Venur
Neuro-Oncologist, University of Washington Medicine and Seattle Cancer Alliance
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
Assistant Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center

Dr. Vyshak Venur

Clinical Trials in Treating Brain Tumors
The Current Clinical Trial Landscape for Patients with Primary Brain Tumors

Dr. Venur discusses the drug development process and the importance of clinical trials. Patients can enter a trial at various points in their treatment and disease progression. In this talk, Dr. Venur describes ongoing trials in the areas of targeted therapies, novel systemic therapies, immunotherapy, and medical devices.
View this presentation
Dr. Patel photo
Dr. Anoop Patel
Neurosurgeon, University of Washington School of Medicine and Seattle Cancer Care Alliance
Assistant Professor, Department of Neurological Surgery, University of Washington School of Medicine

Dr. Anoop Patel

Brain Tumor Tissue Profiling
Surgical Trials and Future Directions in Brain Tumor Treatment

Dr. Patel provides an overview of the types of brain tumors and their treatments. He discusses the development of new treatments through surgical trials including interventional trials and tissue sampling trials. Precision medicine, a personalize approach based on single-cell sequencing of tumor samples, has great promise for new brain cancer treatments.
View this presentation
Dr. Hanoul
Dr. Piet Hanoul
Head of Global Medical Affairs, Novocure

Dr. Piet Hanoul

Introduction to Tumor-Treating Fields

Dr. Piet Hanoul describes the science behind tumor-treating fields, which are low-intensity, intermediate frequency, alternating electric fields. These fields deliver energy at a distance that disrupts the cell division process. The frequency of the tumor-treating fields can be tuned to impact specific cancers. Novocure has developed the Optune medical device, based on tumor-treating fields, for the treatment of brain cancer.
View this presentation
Jeanneane and Jennie
Jeanneane and Her Caregiver Jennie


Finding Hope and Trust - How GBM Changed My Life

Jeanneane was diagnosed with grade-4 GBM in her 30’s. Her treatment followed the standard of care along with a special diet and the use of the Optune medical device. Jeanneane describes how the disease changed her life and caused a feeling of a loss of control, but she remains hopeful and has learned to be trusting of her medical team, caregivers, and family.
View this presentation


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram